CORMORANT ASSET MANAGEMENT, LP – Ascendis Pharma A/S Transaction History
CORMORANT ASSET MANAGEMENT, LP portfolio value:
$5.16M
portfolio value
CORMORANT ASSET MANAGEMENT, LP quarter portfolio value change:
+11.08%
quarter
Ascendis Pharma A/S 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | 0.00% | 0 shares | 515K | $103.26 | 50K | |
| Q2 2022 | share | 0.00% | 0 shares | -1.22M | $92.96 | 50K | |
| Q1 2022 | share | 0.00% | 0 shares | -858K | $117.36 | 50K | |
| Q4 2021 | share | Decrease | -70.59% | -120K shares | -20.37M | $136.41 | 50K |
| Q3 2021 | share | Increase | +126.67% | 95K shares | 17.23M | $159.39 | 170K |
| Q2 2021 | share | Decrease | -25.00% | -25K shares | -3.02M | $131.55 | 75K |
| Q1 2021 | share | 0.00% | 0 shares | -3.79M | $128.88 | 100K | |
| Q4 2020 | share | Decrease | -20.00% | -25K shares | -2.61M | $166.78 | 100K |
| Q3 2020 | share | Decrease | -28.57% | -50K shares | -6.59M | $154.32 | 125K |
| Q2 2020 | call | Decrease | -100.00% | -350K shares | -39.41M | $147.9 | 0 |
| Q2 2020 | share | Decrease | -30.00% | -75K shares | -2.27M | $147.9 | 175K |
| Q1 2020 | call | Increase | +40.00% | 100K shares | 4.63M | $112.61 | 350K |
| Q1 2020 | share | Decrease | -37.50% | -150K shares | -27.49M | $112.61 | 250K |
| Q4 2019 | call | 0.00% | 0 shares | 10.7M | $139.12 | 250K | |
| Q4 2019 | share | Decrease | -14.58% | -68.3K shares | 10.54M | $139.12 | 400K |
| Q3 2019 | call | 0.00% | 0 shares | -4.70M | $96.32 | 250K | |
| Q3 2019 | share | Increase | +17.07% | 68.3K shares | -953K | $96.32 | 468.3K |
| Q2 2019 | call | Increase | 0.00% | 250K shares | 28.78M | $115.15 | 250K |
| Q2 2019 | share | Decrease | -33.33% | -200K shares | -24.56M | $115.15 | 400K |
| Q1 2019 | share | Increase | +77.28% | 261.54K shares | 49.41M | $117.7 | 600K |
| Q4 2018 | share | Decrease | -3.30% | -11.54K shares | -3.59M | $62.65 | 338.45K |
| Q3 2018 | share | Decrease | -5.85% | -21.73K shares | 73K | $70.86 | 350K |
| Q2 2018 | share | 0.00% | 0 shares | 416K | $66.52 | 371.73K | |
| Q1 2018 | share | Increase | +23.91% | 71.73K shares | 12.29M | $65.4 | 371.73K |
| Q4 2017 | share | Increase | 0.00% | 300K shares | 12.01M | $40.06 | 300K |
| Q2 2017 | share | Decrease | -100.00% | -100K shares | -2.8M | $27.76 | 0 |
| Q1 2017 | share | Decrease | -38.37% | -62.25K shares | -484K | $28 | 100K |
| Q4 2016 | share | Increase | +160.63% | 100K shares | 2.03M | $20.24 | 162.25K |
| Q3 2016 | share | 0.00% | 0 shares | 425K | $20.1 | 62.25K | |
| Q2 2016 | share | Increase | +1.23% | 754 shares | -315K | $13.27 | 62.25K |
| Q1 2016 | share | 0.00% | 0 shares | 14K | $18.55 | 61.5K |